JAN 23, 2018 12:00 PM PST

WEBINAR: Bringing Novel Biomarkers from Research to Clinical Use

SPONSORED BY: Sphingotec LLC
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Chair, Division of Clinical Core Laboratory Services, Department of Laboratory Medicine and Pathology, Mayo Clinic
    Biography
      Allan S. Jaffe, M.D., is a Consultant and Chair of the Division of Clinical Core Laboratory Services at Mayo Clinic in Rochester, Minnesota, with a joint appointment in the Department of Cardiovascular Diseases. He holds the academic rank of Professor of Laboratory Medicine and Pathology and also Professor of Medicine.
    • Co-Director, Cardiovascular Laboratory Medicine, Mayo Clinic
      Biography
        Dr. Meeusen received a PhD from the University of Wisconsin studying inorganic biochemistry. After graduate school he spent three years as a post-doctoral research fellow supporting Mayo Medical Laboratories esoteric test development. Dr. Meeusen's research interests include lipid and lipoprotein testing and he is currently co-director of Cardiovascular Laboratory Medicine at Mayo Clinic.
      • Co-Director, Cardiovascular Laboratory Medicine; Co-Director, Hospital Clinical Laboratory and Point-of-Care Testing, Mayo Clinic
        Biography
          Leslie J. Donato, Ph.D., DABCC, Co-Director of the Cardiovascular Laboratory Medicine and Co-Director of the Hospital Clinical Laboratory and Point-of-Care Testing at Mayo Clinic in Rochester, Minnesota. She is a Consultant in the Division of Clinical Core Laboratory Services in the Department Laboratory Medicine and Pathology.

        Abstract:

        DATE: January 23, 2018
        TIME: 12:00 PM PST, 3:00 PM EST

        The translation of basic scientific research to clinical application in the hospital or clinic setting is vital for advancing the quality of patient care. This is particularly true in the clinical laboratory when hospital labs evaluate new biomarkers for potential clinical use as a laboratory developed test (LDT).

        The numerous steps taken to evaluate the analytical and clinical performance of each novel biomarker are critical to this process before the test can be ordered. These steps ensure the test results are accurate and reproducible when performed by laboratory technologists and confirm that results can be used to improve disease diagnostics or prognostics.

        Here we will describe the process a major academic medical center takes to critically evaluate novel biomarkers for various clinical applications and provide examples of such novel biomarkers that are either under evaluation or have been recently completed.

        Learning Objectives:

        • Understand what factors are important to consider when deciding which novel biomarker to evaluate for clinical use
        • Understand the importance and challenges of analytical validations of assays for novel biomarkers
        • Understand the importance and challenges of clinical validations of assays for novel biomarkers

        Show Resources
        You May Also Like
        MAY 24, 2018 09:30 AM PDT
        C.E. CREDITS
        MAY 24, 2018 09:30 AM PDT
        DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
        AUG 15, 2018 08:00 AM PDT
        C.E. CREDITS
        AUG 15, 2018 08:00 AM PDT
        DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
        JUN 20, 2018 10:00 AM EDT
        C.E. CREDITS
        JUN 20, 2018 10:00 AM EDT
        DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
        JUN 26, 2018 06:00 AM PDT
        C.E. CREDITS
        JUN 26, 2018 06:00 AM PDT
        Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
        MAY 03, 2018 11:00 AM PDT
        MAY 03, 2018 11:00 AM PDT
        DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
        MAY 22, 2018 08:00 AM PDT
        C.E. CREDITS
        MAY 22, 2018 08:00 AM PDT
        DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
        Loading Comments...